Litcius/Paper detail

Post-treatment cell-free DNA as a predictive biomarker in molecular-targeted therapy of hepatocellular carcinoma

T. Nakatsuka, Hayato Nakagawa, Yuki Hayata, Taijiro Wake, Tomoharu Yamada, Mizuki Nishibatake Kinoshita, Ryo Nakagomi, Masaya Sato, Tatsuya Minami, Koji Uchino, Kenichiro Enooku, Yotaro Kudo, Yasuo Tanaka, Takahiro Kishikawa, Motoyuki Otsuka, Ryosuke Tateishi, Kazuhiko Koike

2021Journal of Gastroenterology26 citationsDOI

Topics & Concepts

Hepatocellular carcinomaMedicineLiquid biopsyInternal medicineOncologyBiomarkerSurgical oncologyTargeted therapyCell-free fetal DNADigital polymerase chain reactionLenvatinibCancer researchCancerGeneSorafenibPolymerase chain reactionBiologyGeneticsFetusPregnancyPrenatal diagnosisCancer Genomics and DiagnosticsCancer Cells and MetastasisHepatocellular Carcinoma Treatment and Prognosis
Post-treatment cell-free DNA as a predictive biomarker in molecular-targeted therapy of hepatocellular carcinoma | Litcius